Correlation Between Exelixis and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Exelixis and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Seres Therapeutics, you can compare the effects of market volatilities on Exelixis and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Seres Therapeutics.
Diversification Opportunities for Exelixis and Seres Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Exelixis and Seres is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Exelixis i.e., Exelixis and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Exelixis and Seres Therapeutics
Given the investment horizon of 90 days Exelixis is expected to generate 0.26 times more return on investment than Seres Therapeutics. However, Exelixis is 3.82 times less risky than Seres Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Seres Therapeutics is currently generating about -0.02 per unit of risk. If you would invest 1,605 in Exelixis on September 3, 2024 and sell it today you would earn a total of 2,041 from holding Exelixis or generate 127.17% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exelixis vs. Seres Therapeutics
Performance |
| Timeline |
| Exelixis |
| Seres Therapeutics |
Exelixis and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exelixis and Seres Therapeutics
The main advantage of trading using opposite Exelixis and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
| Seres Therapeutics vs. DiaMedica Therapeutics | Seres Therapeutics vs. Lyra Therapeutics | Seres Therapeutics vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |